CN1504210A

CN1504210A - Prepared Chinese traditional medicine for alopecia

Info

Publication number: CN1504210A
Application number: CNA021395616A
Authority: CN
Inventors: 勇韩; 韩勇
Original assignee: Individual
Current assignee: Individual
Priority date: 2002-11-28
Filing date: 2002-11-28
Publication date: 2004-06-16
Anticipated expiration: 2022-11-28
Also published as: CN1269506C

Abstract

The invention relates to a traditional Chinese hair tonic preparation for preventing alopecia, whose constituents (percentage by weight) are, atractylodes rhizome (1%-20%), white atractylodes rhizome (1%-12%), root of pilose asiabell (3%-30%), Chinese angelica root (2%-27%), rhizome of Sichuan lovage (1%018%), Bupleurum root (3%-25%). The invention has shown stable and reliable curative effect for various hair diseases, and can be provided with various does types such as powder, pill and capsule.

Description

A kind of Chinese patent medicine preparation for the treatment of alopecia

Technical field

The present invention relates to a kind of medicinal preparation, especially a kind ofly be used for anti-loss and promote the Chinese patent medicine preparation of hair growth promoting.

Background technology

Alopecia has caused serious thought pressure to the patient, thereby normal work, study, life and doings are affected.Yet, still do not have hair diseases such as special effect medicine therapeutic seborrheic alopecia, sending alopecia early, alopecia areata, alopecia totalis, alopecia universalis, puerperal alopecia at present.

Summary of the invention

The invention solves the technical problem of hair illness such as no special effect medicine therapeutic seborrheic alopecia, sending alopecia early, alopecia areata, alopecia totalis, alopecia universalis, puerperal alopecia in the background technology.

Technical scheme of the present invention is: it is Rhizoma Atractylodis (1%-20%) that percentage by weight of the present invention is formed; The Rhizoma Atractylodis Macrocephalae (stir-fry) (1%-12%); Radix Codonopsis (3%-30%); Radix Angelicae Sinensis (2%-27%); Rhizoma Chuanxiong (1%-18%); Radix Bupleuri (3%-25%).

It also includes the Radix Astragali (1%-20%); Radix Polygoni Multiflori (system) (0.5%-10%); The Rhizoma Pinelliae (clear system) (0.5%-2%); Polyporus (1%-10%); Poria (0.5%-10%); Semen Plantaginis (0.5%-10%); Rhizoma Alismatis (0.5%-10%); Semen Coicis (3%-30%); Flos Carthami (3%-30%); Radix Saposhnikoviae (0.1%-10%); Radix Paeoniae Rubra (3%-30%); Radix Salviae Miltiorrhizae (3%-30%); Semen Persicae (3%-30%); Pericarpium Citri Reticulatae (5%-30%); Fructus Aurantii (1%-10%);

It also includes Herba Pogostemonis (3%-30%); Herba Eupatorii (3%-30%); Herba Lycopi (3%-30%); Rhizoma Corydalis (3%-30%); Pericarpium Citri Reticulatae Viride (1%-30%); Cortex Magnoliae Officinalis (0.5%-20%).

It also includes the Radix Angelicae Dahuricae (1%-10%); Radix Platycodonis (3%-30%).

The present invention faces the card experience according to the traditional Chinese medical science several thousand, and inventor's clinical experience for many years, find most patient's alopecias owing to the physical function imbalance causes, the key of its etiology and pathogenesis is exactly because the blood stasis blood deficiency makes scalp Rhizoma Imperatae blood supply insufficiency, hair is lost support, thereby cause alopecia.The present invention adopted just the pathogenesis that hits replenishing QI to invigorate the spleen, enrich blood, the natural plants Chinese medicine of expelling wind and removing dampness, promoting flow of QI and blood, blood stasis dispersing and fresh blood promoting, hair growth accelerating, be based on effecting a permanent cure, make that energy and blood of human body abundance, ailment said due to cold or exposure are dispeled, blood vessels are unimpeded, thereby make hair obtain nourishing, reach the purpose of treatment hair disease.The present invention can adopt Chinese powder medicine, does not destroy any effective ingredient in the medical material, is easily absorbed by the body, and makes stable curative effect reliable.It also can be made into multiple dosage forms such as pill, capsule.

The specific embodiment

According to Chinese medical theory, " send out and be Crinis Carbonisatus ", it is foster that the growth of human hair relies on moistening of blood in other words, and the key that causes alopecia is exactly because the blood stasis blood deficiency makes scalp Rhizoma Imperatae blood supply insufficiency, hair is lost support.Cause the pathogenesis of blood in human body in blood stasis void then to mainly contain following reason:

If ponder over, work hard, overwork or eating and drinking without temperance, eating cold and uncooked food excessively, addiction to greasy and sweet foods, of a specified duration all can cause insufficiency of the spleen leading to overabundance of dampness.Change source deficiency can cause blood deficiency, and dampness hampering qi movement then can cause qi depression to blood stasis; Feelings will is not smooth, depression of liver-QI, can cause qi depression to blood stasis yet.

Because essence and blood sharing the same origin, essence are hindered then blood wound, so excess of sexual intercourse can cause blood deficiency; Lose blood puerperal simultaneously, wound loses blood and also can cause blood deficiency.

Therefore the present invention is directed to the above pathogenesis that causes alopecia, be based on effecting a permanent cure, develop this Chinese medicine preparation.It comprises Rhizoma Atractylodis (1%-20%); The Rhizoma Atractylodis Macrocephalae (stir-fry) (1%-12%); The Radix Astragali (1%-20%); Radix Codonopsis (3%-30%); Radix Angelicae Sinensis (2%-27%); Radix Polygoni Multiflori (system) (0.5%-10%); The Rhizoma Pinelliae (clear system) (0.5%-2%); Polyporus (1%-10%); Poria (0.5%-10%); Semen Plantaginis (0.5%-10%); Rhizoma Alismatis (0.5%-10%); Semen Coicis (3%-30%); Herba Pogostemonis (3%-30%); Herba Eupatorii (3%-30%); Rhizoma Chuanxiong (1%-18%); Flos Carthami (3%-30%); Radix Saposhnikoviae (0.1%-10%); Radix Paeoniae Rubra (3%-30%); Herba Lycopi (3%-30%); Radix Salviae Miltiorrhizae (3%-30%); Rhizoma Corydalis (3%-30%); Semen Persicae (3%-30%); Pericarpium Citri Reticulatae (5%-30%); Pericarpium Citri Reticulatae Viride (1%-30%); Fructus Aurantii (1%-10%); Cortex Magnoliae Officinalis (0.5%-20%); Radix Bupleuri (3%-25%); The Radix Angelicae Dahuricae (1%-10%); Radix Platycodonis (3%-30%).

Wherein Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae (stir-fry), Radix Codonopsis, Radix Angelicae Sinensis, Rhizoma Chuanxiong and Radix Bupleuri are principal agent, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae (stir-fry) but invigorating the spleen and benefiting QI, activating the spleen damp eliminating; But Radix Codonopsis invigorating the spleen and replenishing QI; Radix Angelicae Sinensis can be enriched blood, be invigorated blood circulation; But Rhizoma Chuanxiong blood circulation promoting and blood stasis dispelling; But Radix Bupleuri depressed liver-energy dispersing and QI regulating.

Pericarpium Citri Reticulatae, Fructus Aurantii, the Rhizoma Pinelliae (clear system), Polyporus, Poria, Semen Plantaginis, Rhizoma Alismatis, the Radix Astragali, Flos Carthami, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Semen Persicae, Radix Saposhnikoviae, Radix Polygoni Multiflori (system) and Semen Coicis are accessory drugs, and Pericarpium Citri Reticulatae can be regulated the flow of vital energy, and are used for strengthening the effect of the spleen invigorating of Rhizoma Atractylodis; But the Fructus Aurantii circulation of qi promoting is used for strengthening the soothing the liver effect of Radix Bupleuri; Come the dampness stomach function regulating with the Rhizoma Pinelliae (clear system), come promoting diuresis to eliminate damp pathogen with Polyporus, Poria, Semen Plantaginis and Rhizoma Alismatis, to strengthen the effect of Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae (stir-fry) invigorating the spleen to clear away damp pathogen; Strengthen the effect of Radix Codonopsis QI invigorating with the Radix Astragali; Strengthen the effect that Rhizoma Chuanxiong is invigorated blood circulation with Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, Semen Persicae and Flos Carthami.

Herba Pogostemonis, Herba Eupatorii, Cortex Magnoliae Officinalis, Herba Lycopi, Rhizoma Corydalis and Pericarpium Citri Reticulatae Viride are adjuvant drug.But Herba Pogostemonis, Herba Eupatorii removing dampness by means of aromatics; The feasible conductance of Cortex Magnoliae Officinalis stagnates; But Herba Lycopi, Rhizoma Corydalis blood circulation promoting and blood stasis dispelling; Pericarpium Citri Reticulatae Viride can be regulated the flow of vital energy.

The Radix Angelicae Dahuricae, Radix Platycodonis are messenger drug, and priming is up, through sick institute.

The present invention's Rhizoma Atractylodis, it both can the same Rhizoma Atractylodis Macrocephalae (stir-fry), the Rhizoma Pinelliae (clear system), Polyporus, Poria, Semen Plantaginis, Rhizoma Alismatis, Semen Coicis, Herba Pogostemonis, Herba Eupatorii, the Radix Astragali, Radix Codonopsis cooperate the effect that reaches invigorating the spleen to clear away damp pathogen, QI invigorating and blood producing, can cooperate Radix Saposhnikoviae, Radix Polygoni Multiflori (system) to reach and dispel ailment said due to cold or exposure again, blood vessels must be logical, and hair must be supported.

Because incur loss through delay sometimes when this disease is gone to a doctor, the stasis of blood stagnates for a long time more, so cooperate group's blood circulation promoting medicines such as Flos Carthami, Semen Persicae, Radix Paeoniae Rubra, Herba Lycopi, Radix Salviae Miltiorrhizae with Rhizoma Chuanxiong, dredges its blood vessels.Cooperate QI regulating medicine such as Fructus Aurantii, Pericarpium Citri Reticulatae Viride to strengthen the merit of blood circulation promoting and blood stasis dispelling simultaneously.In view of primary disease, though blood deficiency is arranged, mostly be insufficiency of the spleen leading to overabundance of dampness, the change source is not enough and cause the hemopoietic deficiency, if with the greasy product of enriching blood of multiple taste, common merit of enriching blood does not reach, and decreases resembling and giving birth to of damage of the spleen stomach, so use in the side Radix Polygoni Multiflori, Radix Angelicae Sinensis with its blood.

Clinical alopecia causes because of normal heterozygosis, causes a disease jointly or reciprocal causation.How and not assorted during event was write out a prescription, medicine was established at the Different types of etiopathogenises pathogenesis,, and is numerous and not random, respectively has it main, and each medicine share, and reaches the same goal very on the way, plays hemopoietic altogether to promote blood circulation the merit of hair growth accelerating.

Production technology of the present invention following (is example with the powder production technology):

1) sampling observation medical material, clean;

2) adopt and to guarantee that the method for the non-volatile medical material property of medicine dries medical material;

3) with the medical material proportioning, pulverize, sieve;

4) sterilization;

5) mix;

6) packing.

Below be concrete proportioning example of the present invention:

The Herba Lycopi	????3	????3	????3.5
The Herba Lycopi	????3	????3	????3.5	Radix Salviae Miltiorrhizae	????3	????3	????5
Rhizoma Corydalis	????3	????3	????3	Radix Salviae Miltiorrhizae	????3	????3	????5
Rhizoma Corydalis	????3	????3	????3	Semen Persicae	????3	????3	????4
Pericarpium Citri Reticulatae	????5	????5	????5.5	Semen Persicae	????3	????3	????4
Pericarpium Citri Reticulatae	????5	????5	????5.5	Pericarpium Citri Reticulatae Viride	????2	????1	????1
Fructus Aurantii	????1	????1	????1	Pericarpium Citri Reticulatae Viride	????2	????1	????1
Fructus Aurantii	????1	????1	????1	Cortex Magnoliae Officinalis	????0.7	????0.5	????0.5
Radix Bupleuri	????9	????11	????10.5	Cortex Magnoliae Officinalis	????0.7	????0.5	????0.5
Radix Bupleuri	????9	????11	????10.5	The Radix Angelicae Dahuricae	????1	????1	????1.5
Radix Platycodonis	????3	????3	????3.5	The Radix Angelicae Dahuricae	????1	????1	????1.5

Claims

1, a kind of Chinese patent medicine preparation for the treatment of alopecia is characterized in that: it is Rhizoma Atractylodis (1%-20%) that the percentage by weight of the Chinese patent medicine preparation of this treatment alopecia is formed; The Rhizoma Atractylodis Macrocephalae (stir-fry) (1%-12%); Radix Codonopsis (3%-30%); Radix Angelicae Sinensis (2%-27%); Rhizoma Chuanxiong (1%-18%); Radix Bupleuri (3%-25%).

2, the Chinese patent medicine preparation of treatment alopecia as claimed in claim 1 is characterized in that: the Chinese patent medicine preparation of described treatment alopecia also includes the Radix Astragali (1%-20%); Radix Polygoni Multiflori (system) (0.5%-10%); The Rhizoma Pinelliae (clear system) (0.5%-2%); Polyporus (1%-10%); Poria (0.5%-10%); Semen Plantaginis (0.5%-10%); Rhizoma Alismatis (0.5%-10%); Semen Coicis (3%-30%); Flos Carthami (3%-30%); Radix Saposhnikoviae (0.1%-10%); Radix Paeoniae Rubra (3%-30%); Radix Salviae Miltiorrhizae (3%-30%); Semen Persicae (3%-30%); Pericarpium Citri Reticulatae (5%-30%); Fructus Aurantii (1%-10%);

3, the Chinese patent medicine preparation of treatment alopecia as claimed in claim 2 is characterized in that: the Chinese patent medicine preparation of described treatment alopecia also includes Herba Pogostemonis (3%-30%); Herba Eupatorii (3%-30%); Herba Lycopi (3%-30%); Rhizoma Corydalis (3%-30%); Pericarpium Citri Reticulatae Viride (1%-30%); Cortex Magnoliae Officinalis (0.5%-20%).

4, the Chinese patent medicine preparation of treatment alopecia as claimed in claim 3 is characterized in that: the Chinese patent medicine preparation of described treatment alopecia also includes the Radix Angelicae Dahuricae (1%-10%); Radix Platycodonis (3%-30%).